![]() |
Volumn 94, Issue 6, 2001, Pages 287-291
|
MHC and the viral hepatitides
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA 2 MICROGLOBULIN;
CARRIER PROTEIN;
CD4 ANTIGEN;
COMPLEMENT;
CYTOKINE;
HEPATITIS B VACCINE;
HLA ANTIGEN CLASS 1;
HLA ANTIGEN CLASS 2;
HLA DR ANTIGEN;
HLA DR13 ANTIGEN;
HLA DR4 ANTIGEN;
HLA DR7 ANTIGEN;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
T LYMPHOCYTE RECEPTOR;
UNCLASSIFIED DRUG;
ALLELE;
ANTIGEN PRESENTATION;
ANTIGEN PRESENTING CELL;
CELL INTERACTION;
CELL MEMBRANE;
CHROMOSOME 6;
CHROMOSOME ARM;
CONTROLLED STUDY;
CYTOPLASM;
CYTOTOXIC T LYMPHOCYTE;
DISEASE ASSOCIATION;
DISEASE MARKER;
EDITORIAL;
ENDOPLASMIC RETICULUM;
ENVIRONMENTAL FACTOR;
FEMALE;
GENE LOCUS;
GENETIC POLYMORPHISM;
HELPER CELL;
HEPATITIS B;
HEPATITIS C;
HEREDITY;
HETEROZYGOTE;
HUMAN;
HUMAN CELL;
IMMUNE RESPONSE;
INFECTION;
INFECTION RESISTANCE;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER FAILURE;
MAJOR HISTOCOMPATIBILITY COMPLEX;
MALE;
MORTALITY;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SYMPTOM;
VIRUS HEPATITIS;
VIRUS VIRULENCE;
|
EID: 0034949373
PISSN: 14602725
EISSN: None
Source Type: Journal
DOI: 10.1093/qjmed/94.6.287 Document Type: Editorial |
Times cited : (29)
|
References (32)
|